Sarepta Therapeutics
SRPT
SRPT
393 hedge funds and large institutions have $10.1B invested in Sarepta Therapeutics in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 154 increasing their positions, 125 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
1.34% more ownership
Funds ownership: 87.92% → 89.27% (+1.3%)
7% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 54
2% less funds holding
Funds holding: 402 → 393 (-9)
Holders
393
Holding in Top 10
8
Calls
$650M
Puts
$524M
Top Buyers
| 1 | +$230M | |
| 2 | +$221M | |
| 3 | +$69.4M | |
| 4 |
BlackRock
New York
|
+$64.3M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$48.5M |
Top Sellers
| 1 | -$419M | |
| 2 | -$73.1M | |
| 3 | -$58M | |
| 4 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$36.9M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$36.1M |